# Nurix Therapeutics, Inc. (NRIX) - Q1 2026 earnings

Reported April 8, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $6.3M | $14.3M |
| EPS | $-0.79 | $-0.76 |

Earnings filing reader: [8-K 0001549595-26-000024](https://www.opencapital.sh/filings/0001549595-26-000024)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001549595-26-000024.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000024/0001549595-26-000024-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1549595/000154959526000025/0001549595-26-000025-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/nrix/earnings/q1-2026